CVS Health Corporation (NYSE:CVS) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 24,837,344 shares, a growth of 16.1% from the October 13th total of 21,400,669 shares. Approximately 2.5% of the shares of the company are sold short. Based on an average trading volume of 10,995,147 shares, the short-interest ratio is presently 2.3 days.

CVS Health Corporation (CVS) opened at $70.68 on Monday. CVS Health Corporation has a 52 week low of $66.45 and a 52 week high of $84.72. The stock has a market capitalization of $71,598.27, a P/E ratio of 12.38, a P/E/G ratio of 1.21 and a beta of 0.86. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The company had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. During the same quarter in the prior year, the firm earned $1.64 earnings per share. CVS Health Corporation’s revenue was up 3.5% compared to the same quarter last year. analysts expect that CVS Health Corporation will post 5.9 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.83%. CVS Health Corporation’s dividend payout ratio (DPR) is currently 41.32%.

In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the sale, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The disclosure for this sale can be found here. Insiders sold 714,125 shares of company stock valued at $58,119,381 in the last ninety days. 0.61% of the stock is currently owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Horan Capital Advisors LLC. grew its stake in CVS Health Corporation by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after purchasing an additional 1,000 shares in the last quarter. Community Bank N.A. boosted its position in CVS Health Corporation by 7.3% during the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in CVS Health Corporation by 3.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock valued at $13,840,000 after acquiring an additional 5,478 shares in the last quarter. Midwest Investment Management LLC boosted its position in CVS Health Corporation by 6.2% during the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after acquiring an additional 1,245 shares in the last quarter. Finally, Fiduciary Trust Co. boosted its position in CVS Health Corporation by 1.2% during the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after acquiring an additional 4,265 shares in the last quarter. 81.42% of the stock is currently owned by institutional investors.

Several equities analysts have recently commented on the company. BidaskClub upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Needham & Company LLC upgraded CVS Health Corporation from a “hold” rating to a “buy” rating and boosted their price objective for the company from $69.02 to $79.00 in a research report on Friday, November 10th. Citigroup Inc. lowered their price objective on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Thursday, August 17th. Jefferies Group LLC lowered their price objective on CVS Health Corporation from $86.00 to $76.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Finally, Loop Capital lowered their price objective on CVS Health Corporation from $83.00 to $73.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and a consensus target price of $85.82.

COPYRIGHT VIOLATION WARNING: “CVS Health Corporation (CVS) Sees Large Increase in Short Interest” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/11/20/cvs-health-corporation-cvs-sees-large-increase-in-short-interest.html.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.